Changes in memory and thinking are not always an inevitable consequence of getting older. Some aspects of cognition change normally with age, while others may signal vascular injury, neurodegenerative disease, medication effects, sleep disorders, metabolic dysfunction, nutritional deficiencies, or other potentially modifiable problems.
Brain health therefore deserves the same proactive attention we give to cardiovascular, metabolic, and bone health. Changes in the brain often develop gradually, sometimes beginning years before they become obvious in everyday life. Understanding risk earlier creates more opportunities to protect function, build resilience, and intervene when appropriate.
How Brain Aging and Dementia Are Connected
The brain changes throughout life. Processing speed may become somewhat slower with age, and it can take longer to retrieve a name or piece of information. That is different from progressive difficulty learning new information, managing familiar tasks, navigating, communicating, or functioning independently.
Dementia is not one disease. It is a clinical syndrome caused by changes in the brain significant enough to interfere with daily function. Alzheimer’s disease is the most common cause, but vascular disease, Lewy body disease, frontotemporal degeneration, Parkinson-related disease, and other conditions can also contribute.
Importantly, more than one process can occur at the same time. An individual may have Alzheimer-related amyloid and tau pathology along with small-vessel disease, metabolic dysfunction, inflammation, sleep apnea, medication effects, or other factors influencing cognitive function.
This is one reason a precision approach to brain health can be useful. Rather than assuming every change in cognition has one cause, we can look at the different systems influencing the brain and identify areas that may be modifiable.
Alzheimer’s Disease
Alzheimer’s disease is associated with abnormal accumulation of beta-amyloid and tau proteins in the brain, along with changes in synaptic function, inflammation, energy metabolism, and ultimately loss of neurons.
Research increasingly shows that these pathological changes can begin long before dementia develops.
This does not mean that the presence of amyloid automatically determines a person’s future. Brain function reflects the interaction of pathology with vascular health, metabolic health, inflammation, sleep, genetics, cognitive reserve, physical activity, nutrition, and other factors.
Vascular Cognitive Impairment
The brain depends on a constant supply of oxygen and nutrients from an extensive network of blood vessels.
Damage to large or small cerebral blood vessels can affect cognition directly. Vascular cognitive impairment exists on a spectrum, ranging from relatively subtle changes in executive function and processing speed to vascular dementia.
Hypertension is particularly important. Blood pressure and blood-pressure variability are consistently associated with cerebral small-vessel disease and progression of white matter abnormalities.
This is why we do not consider heart health and brain health to be separate subjects.
White Matter Hyperintensities
White matter hyperintensities, or WMHs, are areas that appear brighter on certain MRI sequences. They become more common with age and are frequently associated with cerebral small-vessel disease.
They are not all equivalent, and the mechanisms behind them are more complex than simply “poor circulation.” Current research implicates hypertension, vascular injury, blood-brain barrier changes, inflammation, impaired blood flow, arterial stiffness, genetics, and altered fluid clearance among other factors.
A greater white matter burden has been associated with cognitive impairment and vascular dementia risk.
For patients who already have WMHs on an MRI, the finding can therefore become a reason to look more carefully at blood pressure, metabolic health, vascular function, sleep apnea, smoking, physical activity, and other modifiable contributors.
Why Vascular and Metabolic Health Matter for the Brain
The same factors that affect the heart and blood vessels also affect the brain.
Hypertension, diabetes, insulin resistance, obesity, abnormal lipids, smoking, physical inactivity, and sleep disturbances are associated with greater risk of cognitive decline. Importantly, many of these exposures begin in midlife, decades before dementia becomes clinically apparent.
This creates an important opportunity.
Brain-health prevention does not need to begin when memory problems appear. It can begin with controlling blood pressure, supporting insulin sensitivity, improving body composition, treating sleep disorders, exercising, and reducing other vascular and metabolic stressors much earlier.
Blood Pressure
Both chronically elevated blood pressure and abnormal nighttime blood-pressure patterns can affect the cerebral circulation.
For selected patients, looking beyond a single office reading with home or 24-hour ambulatory blood-pressure monitoring can provide useful information about the vascular environment affecting the brain.
Blood Sugar and Insulin
Insulin resistance and diabetes are associated with increased dementia risk through several overlapping mechanisms, including vascular disease, inflammation, oxidative stress, and changes in brain energy metabolism.
Supporting metabolic health is therefore part of supporting brain health.
Lipids and Vascular Risk
ApoB-containing lipoproteins contribute to atherosclerosis throughout the vascular system. Elevated Lp(a), smoking, kidney disease, and other cardiovascular risks can also influence the blood vessels that support the brain.
The goal is not to reduce brain health to cardiovascular risk alone. It is to recognize that the brain is highly dependent on healthy circulation.
What Nutrition and Lifestyle Can Do to Support Cognition
There is no single food, supplement, or lifestyle strategy that guarantees protection from dementia.
What is becoming increasingly clear, however, is that brain health appears to respond best to a multidomain approach.
Randomized trials of multidomain interventions have combined nutrition, physical activity, cognitive training, vascular risk management, and other strategies. Results vary by population and program, but recent trials and reviews continue to support the idea that addressing multiple modifiable factors together can improve or preserve cognitive function in people at risk.
Exercise
Physical activity affects the brain directly as well as indirectly.
Aerobic exercise supports cardiovascular fitness, cerebral circulation, metabolic health, and mitochondrial function. Resistance exercise helps preserve muscle and insulin sensitivity. Exercise also influences neurotrophic signaling involved in brain adaptation and plasticity.
For most people, a combination of aerobic activity, resistance training, balance work, and regular everyday movement is more useful than searching for one ideal “brain exercise.”
Nutrition
Dietary patterns associated with cognitive health generally emphasize vegetables, berries and other fruit, nuts, seeds, legumes, fish, olive oil and other unsaturated fats, and minimally processed foods.
The MIND diet, which combines elements of Mediterranean and DASH-style eating patterns, was specifically developed around foods associated with cognitive health.
The evidence is encouraging but nuanced. Observational studies have frequently associated greater MIND-diet adherence with better cognitive outcomes, while randomized trial results have been more variable. More recent analyses suggest that response may differ according to metabolic status, genetics, and Alzheimer-related biomarkers.
That variability reinforces an important principle of precision nutrition: a dietary strategy may be valuable even when every participant in a trial does not respond identically.
Sleep
Sleep is closely linked to memory consolidation, metabolic health, immune signaling, and brain recovery.
Sleep apnea deserves particular attention because repeated nighttime oxygen disruption and fragmented sleep can affect vascular and cognitive health. Persistent insomnia, excessive daytime sleepiness, loud snoring, or witnessed breathing pauses should not simply be accepted as part of aging.
Cognitive Activity and Social Connection
The brain remains capable of adaptation throughout life.
Learning, mentally challenging activities, social engagement, and maintaining purpose and connection may help build cognitive reserve, allowing the brain to function more effectively even in the presence of age-related changes or pathology.
Cognitive activity works best as part of a larger brain-health strategy rather than as a stand-alone “brain game.”
Nutrients and Supplements for Brain Health
Nutritional supplementation can play a role when it is selected for a specific reason.
Examples may include correcting deficiencies, supporting vascular or metabolic health, providing nutrients involved in neuronal membranes and mitochondrial function, or targeting inflammatory and oxidative pathways.
Potential considerations may include omega-3 fatty acids, B vitamins in appropriate individuals, vitamin D when insufficient, magnesium, selected polyphenols, and other nutraceutical approaches.
The key is individualization.
A supplement may make sense because of a documented deficiency, dietary pattern, genetic factor, laboratory result, medication, or particular clinical goal. Another patient may not have the same need.
This is also an area where the evidence continues to evolve. Some nutraceuticals have human clinical data supporting specific cognitive or physiological outcomes, while others are supported more strongly by mechanistic or observational research. At Crossroads, these differences help guide how therapies are selected and monitored rather than requiring every intervention to fit into a simple “proven” or “unproven” category.
Emerging Brain-Directed Therapies
Brain-health care is expanding beyond medications and lifestyle interventions.
Researchers are studying technologies that influence neural activity, cellular energy production, autonomic regulation, sleep, and brain plasticity.
Photobiomodulation
Transcranial photobiomodulation uses red or near-infrared light to influence cellular energy production and signaling in the brain.
This field has moved beyond purely mechanistic research. A 2025 meta-analysis of randomized trials found improvements in several cognitive domains, particularly among people with cognitive impairment, although studies vary considerably in device, wavelength, dose, treatment schedule, and population.
More recent randomized trials in mild cognitive impairment have also reported improvements in measures of global cognition and memory, while emphasizing the need for larger and longer studies.
This makes photobiomodulation a promising emerging tool rather than simply a theoretical therapy. We offer this at Crossroads.
Neurofeedback and Nervous-System Regulation
Neurofeedback and attention-based practices aim to help the brain develop more flexible patterns of activity and regulation.
These approaches may be particularly relevant when stress, sleep, attention, mood, or autonomic imbalance are contributing to how a person feels and functions.
Not every intervention is appropriate for every person, which is why brain-health therapies are best viewed as a toolbox rather than a standardized protocol.
How Cognitive Testing and Biomarkers Can Help Identify Change
One of the challenges in brain health is that subjective memory symptoms do not always correspond neatly with objective cognitive change.
A person can notice changes while still performing normally on basic screening. Conversely, subtle changes in memory, attention, processing speed, or executive function may be measurable before they interfere substantially with daily life.
This makes baseline cognitive testing valuable.
Testing can help establish how a person is functioning now and allow changes to be followed over time.
Cognitive Testing
Different tests evaluate different aspects of cognition, including:
Memory
Attention
Processing speed
Executive function
Reasoning
Reaction time
At Crossroads, Creyos and ViewMind provide different forms of objective cognitive assessment. Creyos uses computerized cognitive tasks to assess domains such as memory, reasoning, and attention. ViewMind combines visual tasks, eye tracking, and artificial intelligence to analyze aspects of cognitive processing.
These tools are not substitutes for a neurological evaluation when symptoms warrant one. Their value lies in providing objective information and a baseline that can be followed over time.
Alzheimer’s Biomarkers
The ability to detect biological features of Alzheimer’s disease is changing rapidly.
Amyloid PET scans and cerebrospinal-fluid testing have traditionally been used to identify amyloid and tau pathology. Blood-based biomarkers, particularly phosphorylated tau measurements and amyloid-related assays, are now becoming clinically useful as well.
Current Alzheimer’s Association guidance supports certain validated blood biomarkers in the diagnostic evaluation of people who already have objective cognitive impairment and are being assessed in specialized memory care. Not all commercially available tests perform equally, and testing should be interpreted within the context of a full clinical evaluation.
This is an important advance, but screening healthy people with every available Alzheimer biomarker is a different question from using validated biomarkers to investigate cognitive impairment.
Genetics
Genetics can also provide context.
The APOE gene influences Alzheimer’s risk, with the APOE ε4 variant associated with increased risk. It is a susceptibility gene, not a diagnosis or prediction of certainty.
Knowing genetic risk can sometimes influence the intensity of prevention efforts or help contextualize other findings, but it should be paired with appropriate counseling and interpretation.
A Precision Approach to Brain Health
Brain aging is rarely explained by one factor.
A useful assessment may consider:
Cognitive testing
Blood pressure and vascular health
Glucose and insulin regulation
Lipids and ApoB
Sleep quality and sleep apnea
Exercise and physical fitness
Nutrition
Nutrient status
Medications
Mood and stress
Hearing and sensory function
Family history and genetics
Brain imaging when appropriate
Alzheimer-related biomarkers when clinically indicated
The objective is not to order every possible test.
It is to identify the factors most likely to matter for the individual patient and then build a strategy that can be followed and adjusted over time.
Brain Health at Crossroads
The Crossroads Brain Health Program takes a multidimensional approach to cognitive wellness.
The program combines objective cognitive assessment with individualized medical, nutritional, and lifestyle strategies. Depending on the individual, the broader brain-health toolbox may also include targeted supplements, neurofeedback, photobiomodulation, PEMF therapy, vagal-supportive therapies, and attention or meditation training. Crossroads currently offers ViewMind and Creyos cognitive testing as well as technologies including Vielight photobiomodulation and NeurOptimal neurofeedback.
The purpose is not to assume every patient needs every intervention.
It is to establish a clearer picture of cognitive function, identify modifiable contributors, build a personalized plan, and monitor how the brain and the person respond over time.
Learn about the Crossroads Brain Health Program
Learn More
Alzheimer’s Risk, Biomarkers & Cognitive Testing
Learn how cognitive testing, APOE genetics, amyloid and tau biomarkers, and tools such as Creyos and ViewMind can help assess cognitive function, establish a baseline, and identify changes that may warrant further evaluation.
